Try our Advanced Search for more refined results
February 27, 2014
AMARIN PHARMACEUTICALS IRELAND LIMITED v. FOOD AND DRUG ADMINISTRATION et al
Case Number:
1:14-cv-00324
Court:
Nature of Suit:
Judge:
Firms
Government Agencies
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
August 11, 2015
FDA, Amarin Bash Watson's Bid To Join Exclusivity Fight
The U.S. Food and Drug Administration and Amarin Pharmaceuticals Ireland Ltd. attacked efforts by Watson Laboratories Inc. to appeal a recent D.C. federal court decision on exclusivity for omega-3 drug Vascepa, arguing Monday that the company's proposed intervention is premature.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login